{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:12:52Z","timestamp":1761718372685,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.revmed.2014.11.004","type":"journal-article","created":{"date-parts":[[2015,1,14]],"date-time":"2015-01-14T01:23:28Z","timestamp":1421198608000},"page":"623-625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bevacizumab\u00a0: un nouveau succ\u00e8s dans la maladie de Rendu-Osler"],"prefix":"10.1016","volume":"36","author":[{"given":"H.","family":"Bennesser Alaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lehraiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hamaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"El Attar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fakhreddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Serraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2014.11.004_bib0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2014.11.004_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.revmed.2013.02.022","article-title":"Maladie de Rendu-Osler","volume":"35","author":"Duffau","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.11.004_bib0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.lpm.2012.11.009","article-title":"Anti-VEGF\u00a0: une avanc\u00e9e th\u00e9rapeutique dans la maladie de Rendu-Osler","volume":"42","author":"Dupuis-Girod","year":"2013","journal-title":"Presse Med"},{"issue":"6","key":"10.1016\/j.revmed.2014.11.004_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2014.11.004_bib0025","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia-associated with mutations in MADH4 (Smad4)","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.11.004_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MAJ.0b013e3182429866","article-title":"Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab","volume":"343","author":"Fleagle","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.revmed.2014.11.004_bib0035","first-page":"818","article-title":"Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1\u00a0as well as high ALK1\u00a0tissue expression","volume":"90","author":"Sadick","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2014.11.004_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","article-title":"Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)","volume":"91","author":"Shovlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.revmed.2014.11.004_bib0045","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/lary.23303","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose","volume":"122","author":"Dheyauldeen","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.revmed.2014.11.004_bib0050","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/lary.21415","article-title":"Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis","volume":"121","author":"Karnezis","year":"2011","journal-title":"Laryngoscope"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314010704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314010704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:51Z","timestamp":1759336551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866314010704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0248866314010704"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2014.11.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bevacizumab\u00a0: un nouveau succ\u00e8s dans la maladie de Rendu-Osler","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}